Analytical Data
-
基因名
S100A15
- Application
-
别名
S100A7A; S100A7L1; S100A7f; S100 calcium-binding protein A7-like 1
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q86SG5
-
表达区间
Ser2~Gln101
-
分子量
15kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
S100A15 is a member of the S100 protein family, known for its role in various intracellular and extracellular processes, including cell growth, differentiation, and motility. The primary interest in researching S100A15 is its involvement in inflammatory responses and its potential implications in various skin diseases, particularly psoriasis and other inflammatory skin disorders. Elevated levels of S100A15 have been observed in psoriatic lesions, suggesting its role as a biomarker for disease activity and a potential therapeutic target. Moreover, S100A15 has been implicated in the modulation of the immune response, influencing the behavior of immune cells, such as keratinocytes and T cells. Understanding the molecular mechanisms underlying the function of S100A15 and its interactions within the immune system could provide insights into novel therapeutic approaches for treating inflammatory conditions. The generation of recombinant S100A15 protein allows for in-depth studies on its structural characteristics, functional roles, and potential interactions with other proteins. This research aims to elucidate the precise biological functions of S100A15 in inflammation and its therapeutic potential, ultimately contributing to more effective treatments for related skin diseases.
